Delphistem logo

Delphistem

Emerging

Delphistem offers personalized iPSC (induced pluripotent stem cell) banking services, enabling individuals to store their cells at their youngest state for future regenerative medicine and disease detection applications.

Best for: Induced Pluripotent Stem Cell BankingEmerging, rapid growth
36
AI Score
Grade D
AI Visibility Score (Beta)
HealthcareInduced Pluripotent Stem Cell BankingWebsiteUpdated October 2026

Company Overview

About Delphistem

Delphistem is a longevity-focused biotech company providing induced pluripotent stem cell (iPSC) storage services for individuals seeking to preserve their biological options for future personalized medicine. The company collects biological samples from clients, reprograms them into iPSCs — cells capable of differentiating into virtually any tissue type — and stores them cryogenically for long-term use in future medical treatments, disease risk detection, and cell replacement therapies.

Business Model & Competitive Advantage

iPSCs represent a significant advance over traditional cord blood banking because they can be generated from adult tissue at any age and can theoretically be differentiated into any cell type needed for therapeutic use. Delphistem''s value proposition is centered on banking cells while they are relatively young and genomically intact, giving individuals a biological asset that could support treatments for conditions including diabetes, Parkinson''s disease, heart disease, and age-related degeneration as regenerative medicine matures.

Competitive Landscape 2025–2026

The company operates at the intersection of the consumer longevity market and clinical cell banking, positioning itself for an anticipated future in which iPSC-derived therapies become standard care. The iPSC banking market is expected to grow substantially through 2030 as regulatory pathways for cell therapies advance and consumer awareness of longevity medicine increases. Delphistem is a small, early-stage company with active operations and a consumer-facing membership model for storage services.

Curated content • Fact-checked and verified

Key Differentiators

Emerging Innovator

Delphistem is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

36
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Doximity logo

Doximity

HealthTech
HealthtechSaasB2bB2cStartupPlatformAi PoweredMobile First

Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic

Headspace logo

Headspace

Healthcare
B2cHealthtechStartupMobile FirstB2b2cScaleup

Headspace is a mental wellness company founded in 2010 by Andy Puddicombe and Rich Pierson that has grown into one of the most widely used mindfulness and meditation apps globally. The platform offers

Noom logo

Noom

Healthcare
StartupB2cHealthtechMobile FirstPlatform

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to beha

Hims & Hers logo

Hims & Hers

Healthcare
HealthtechB2cMobile FirstGlobal

Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for condi

Zocdoc logo

Zocdoc

HealthTech
AnalyticsB2bB2cHealthtechMarketplaceMobile FirstPlatformSaas

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati

Epic Systems logo

Epic Systems

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el

Compare Delphistem with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Delphistem

Claim This Profile

Are you from Delphistem? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Delphistem Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Delphistem vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →